Stock Analysts

Vornado to Divest Assets (MAC) (VMW) (VNO)

Vornado Realty Trust ( VNO ), a real estate investment trust (REIT), recently announced that it has inked deals to sell two properties to undisclosed buyers. The company is going to sell the Reston Executive Center located in Virginia for $126 million and another property in downtown Philadelphia for $60 million. The company will get the combined net proceeds of $89 million from the sales after the repayment of existing loan and closing costs […]

Stock Analysts

Earnings Scorecard: Boeing (BA) (GD) (LMT)

Following the release of third quarter 2012 results, most of the analysts providing estimates for The Boeing Company ( BA ) have raised their earnings estimates for 2012. The revision in estimates mainly reflects the guidance provided by the company. […]

Stock Analysts

Ensco 3Q Beats on Strong Demand (ESV) (NE)

Ensco plc ( ESV ) reported record adjusted third quarter 2012 profit of $1.53 a share, which surpassed the Zacks Consensus Estimate of $1.30. Moreover, the quarterly earnings increased approximately 66% from 92 cents earned in the year-earlier quarter. The substantial jump in the quarterly profit was buoyed by vigorous demand for oil rigs as well as new rigs joining the fleet. […]

Mergers & Acquisitions

The Advisory Board Company Reports Results For Quarter Ended September 30, 2012

The Advisory Board Company Reports Results For Quarter Ended September 30, 2012 Company Reports Quarterly Revenue Growth of 21%, Contract Value Growth of 20%, and Announces Acquisition of ActiveStrategy PR Newswire WASHINGTON, Nov. 1, 2012 WASHINGTON , Nov. 1, 2012 /PRNewswire/ — The Advisory Board Company (NASDAQ: ABCO) today announced financial results for the quarter ended September 30, 2012 , which is the second quarter of our 2013 fiscal year. […]

Stock Analysts

Pipeline Progress at Cubist Pharma (CBST) (OPTR)

Cubist Pharmaceuticals Inc. ( CBST ) recently announced the commencement of a phase III study (n~1,400) regarding its pipeline candidate CB-5945. The long-term safety study, which is a part of the phase III CB-5945 program (n~3,200), is designed to evaluate CB-5945 (0.25 mg twice daily) for treating opioid-induced constipation (OIC) in patients with chronic non-cancer pain. […]

Fast Money Episodes

Trade of the Day: General Motors

[cnbc 3000126431] CNBC’s Jackie DeAngelis reports the NYC Marathon is still on, but many are asking if the risk is worth the reward; and the Fast Money traders discuss why General Motors makes today’s trade of the day. […]

Fast Money Episodes

Sandy’s Economic Effects

[cnbc 3000126432] Sandy could have an effect on jobs and GDP in the future, with Drew Matus, UBS senior U.S. economist; and the Fast Money traders discuss today’s market pops and drops. […]